VERTEX CELL AND GENETIC THERAPIES

LIVE

Serial Number

98195949

Owner

Vertex Pharmaceuticals Incorporated

Attorney

First Use Date

Jun 6, 2024

Filing Date

Sep 25, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

VERTEX CELL AND GENETIC THERAPIES Trademark

Serial Number: 98195949 • Registration: 7883674

VERTEX CELL AND GENETIC THERAPIES is a trademark filed by Vertex Pharmaceuticals Incorporated on September 25, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Vertex Pharmaceuticals Incorporated (4 trademarks)

50 Northern Avenue
Boston, MA 02210

Entity Type: 03

Legal Representation

Attorney of Record

Lisa Tittemore

109 trademarks filed View all →

Correspondence Address

Lisa Tittemore Merchant & Gould P.C.

P.O. Box 2910

Minneapolis, MN 55402-0910

United States

Trademark Details

Filing Date

September 25, 2023

Registration Date

August 5, 2025

First Use Anywhere

June 6, 2024

First Use in Commerce

June 6, 2024

Published for Opposition

July 30, 2024

Goods & Services

Medical and scientific research; medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 2, 2026 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 2, 2026 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 2, 2026 REAP

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 5, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Aug 5, 2025 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 16, 2025 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 12, 2025 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Jun 22, 2025 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 22, 2025 AITU

USE AMENDMENT FILED

Mar 21, 2025 IUAF

TEAS STATEMENT OF USE RECEIVED

Mar 21, 2025 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 24, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 30, 2024 NPUB

PUBLISHED FOR OPPOSITION

Jul 30, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 10, 2024 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 21, 2024 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 20, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 20, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 20, 2024 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 5, 2024 GNRN

NON-FINAL ACTION E-MAILED

Apr 5, 2024 GNRT

NON-FINAL ACTION WRITTEN

Apr 5, 2024 CNRT

ASSIGNED TO EXAMINER

Mar 29, 2024 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 10, 2023 NWOS

NEW APPLICATION ENTERED

Sep 28, 2023 NWAP

Related Trademarks

More from this Owner

THE POVTENZI TRIFECTA

THE POVTENZI TRIFECTA

POVTENZI + YOU

POVTENZI

POVTENZI

POVTENZI

VYKAFTY

More in Same Class

CURATED AS A SERVICE

CURATED AS A SERVICE

GLORIA AI

ATAI THERAPEUTICS

ATAI THERAPEUTICS

Serial #79384715

RETURN RABBIT

LEXION